Please login to the form below

Not currently logged in
Email:
Password:

psoriasis

This page shows the latest psoriasis news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s upadacitinib tops Humira again in arthritis trial

AbbVie’s upadacitinib tops Humira again in arthritis trial

Upadacitinib and AbbVie’s recently-approved IL-23 inhibitor Skyrizi (risankizumab) for psoriasis are critical to AbbVie’s plans to defend its immunology franchise at a time when it is already ... AbbVie feels it has already achieved with Skyrizi in

Latest news

More from news
Approximately 63 fully matching, plus 248 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics